Cost of goods sold analysis and recommendations to reduce costs of co-packaged mifepristone-misoprostol for medical abortion.

Chinery, Lester; Allaouidine, Chadia; Tomazzini, Alessandra; Larson, Melanie; Gülmezoglu, A Metin

Chinery, Lester; Allaouidine, Chadia; Tomazzini, Alessandra; Larson, Melanie; Gülmezoglu, A Metin.

Afiliación

Chinery L; Concept Foundation, Avenue de Sécheron 15, 1202, Geneva, Switzerland.
Allaouidine C; Concept Foundation, Avenue de Sécheron 15, 1202, Geneva, Switzerland.
Tomazzini A; Concept Foundation, Avenue de Sécheron 15, 1202, Geneva, Switzerland.
Larson M; Concept Foundation, Avenue de Sécheron 15, 1202, Geneva, Switzerland.
Gülmezoglu AM; Concept Foundation, Avenue de Sécheron 15, 1202, Geneva, Switzerland. gulmezoglum@conceptfoundation.org.

Reprod Health ; 17(1): 171, 2020 Nov 04.

Article en En | MEDLINE | ID: mdl-33148282

Asunto(s)

Aborto Inducido/estadística & datos numéricos; Mifepristona/economía; Misoprostol/economía; Aborto Inducido/economía; Aborto Inducido/métodos; Bangladesh; China; Análisis Costo-Beneficio; Femenino; Humanos; India; Mifepristona/uso terapéutico; Misoprostol/uso terapéutico; Embarazo

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Mifepristona / Misoprostol / Aborto Inducido Tipo de estudio: Health_economic_evaluation / Prognostic_studies Límite: Female / Humans / Pregnancy País/Región como asunto: Asia Idioma: En Año: 2020 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google